Amit Vaid, MD
Pulmonary Disease · Falls Church, VANPI 1558314658
Payments from drug & device makers
Across 362 payments — averaging $27.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Resmed Corp$2K
- GSK$866
- Genentech USA, Inc.$818
- AstraZeneca$813
- Sanofi$767
- Boehringer Ingelheim$489
- plus $4K from 34 others
What the payments were for
- Consulting fees$2,30823%
- Travel & lodging$651%
- Food & beverage$7,28373%
- Education$2713%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Resmed Corp | 3 | $2,360 |
| GSK | 62 | $866 |
| Genentech USA, Inc. | 37 | $818 |
| AstraZeneca | 47 | $813 |
| Sanofi | 33 | $767 |
| Boehringer Ingelheim | 23 | $489 |
| Amgen | 15 | $368 |
| Regeneron Healthcare Solutions, Inc. | 13 | $363 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $300 |
| Insmed, Inc. | 14 | $267 |
| Baxter Healthcare | 10 | $236 |
| ZOLL Respicardia, Inc. | 2 | $224 |
| Sanofi-aventis U.S. LLC | 3 | $206 |
| Johnson & Johnson(2 entities) | 9 | $171 |
| Mylan Specialty L.p. | 8 | $162 |
| Grifols USA, LLC | 6 | $154 |
| Mallinckrodt Hospital Products Inc. | 5 | $147 |
| Merck | 3 | $133 |
| Actelion Pharmaceuticals US, Inc. | 5 | $101 |
| Philips North America LLC | 5 | $92 |
| United Therapeutics Corporation | 4 | $91 |
| Bayer | 4 | $82 |
| Pfizer | 5 | $76 |
| Novartis | 4 | $75 |
| Electromed, Inc. | 5 | $75 |
| Harmony Biosciences LLC | 3 | $73 |
| Verona Pharma, Inc. | 3 | $60 |
| Gilead | 3 | $58 |
| E.r. Squibb & Sons, L.L.C. | 3 | $47 |
| Sanofi Pasteur Inc. | 2 | $39 |
| Teva Pharmaceuticals USA, Inc. | 1 | $34 |
| Shionogi Inc | 1 | $27 |
| Pulmonx Corporation | 1 | $27 |
| Sunovion Pharmaceuticals Inc. | 1 | $24 |
| Optinose US, Inc. | 1 | $23 |
| Vapotherm Inc | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $17 |
| Shire North American Group Inc | 1 | $15 |
| Circassia Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AirSense$2,308
- remede System$159
How this compares
$9,927 in reported general payments places this provider in the 70th percentile of 317 pulmonary disease providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 70 | $82,317 |
| Spiriva RespimatTiotropium Bromide | 78 | $55,416 |
| Breo ElliptaFluticasone/Vilanterol | 85 | $40,349 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 52 | $37,227 |
| EliquisApixaban | 18 | $26,907 |
| Qvar RedihalerBeclomethasone Dipropionate | 43 | $16,147 |
| Arnuity ElliptaFluticasone Furoate | 44 | $10,604 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $8,697 |
| Incruse ElliptaUmeclidinium Bromide | 12 | $8,164 |
| Spiriva HandihalerTiotropium Bromide | 15 | $7,628 |
| Pulmicort FlexhalerBudesonide | 20 | $7,563 |
| Fluticasone Propionate HfaFluticasone Propionate | 20 | $7,465 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $5,356 |
| Advair DiskusFluticasone Propion/Salmeterol | 11 | $3,466 |
| DuleraMometasone/Formoterol | 11 | $3,219 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta, Anoro Ellipta, Incruse Ellipta | $866 | $150,132225 claims |
| Boehringer IngelheimSpiriva Respimat | $489 | $55,41678 claims |
| AstraZenecaBreztri Aerosphere, Pulmicort Flexhaler, Symbicort | $813 | $50,14783 claims |
| PfizerEliquis | $76 | $26,90718 claims |
| Teva Pharmaceuticals USA, Inc.Qvar Redihaler | $34 | $16,14743 claims |
| MerckDulera | $133 | $3,21911 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 317 pulmonary disease providers in Virginia.
Other pulmonary disease in Falls Church
- Steven NathanFalls Church$2.5M
- Rabih HalabiFalls Church$604K
- Shambhu AryalFalls Church$115K
- Anne BrownFalls Church$76K
- Vikramjit KhangooraFalls Church$71K
- Jared WilkinsonFalls Church$19K
- Shilpa JohriRichmond$1.7M
- Omar MinaiHopewell$1.3M
- Vijay SubramaniamWilliamsburg$1.3M
- Patricia SimeRichmond$572K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.